Print Page  |  Close Window

SEC
10-Q
BIOTELEMETRY, INC. filed this Form 10-Q on 10/31/2018
Entire Document
 << Previous Page | Next Page >>
BIOTELEMETRY, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
(Unaudited)


September 30, 2018 were due primarily to a $5.7 million adjustment to increase accrued liabilities related to the ZTech legal matter (see “Note 15. Legal Proceedings” for details) and an $8.9 million increase to other long-term liabilities.
(in thousands, except lives)
Amount
 
Weighted
Average Life
(Years)
Fair value of assets acquired:
 
 
 
Cash and cash equivalents
$
4,303

 
 
Healthcare accounts receivable
10,089

 
 
Inventory
1,136

 
 
Prepaid expenses and other current assets
3,798

 
 
Property and equipment
27,507

 
 
Other assets
713

 
 
Identifiable intangible assets:
 
 
 
Customer relationships
126,800

 
10
Technology
3,217

 
2.5
Total identifiable intangible assets
130,017

 
 
Total assets acquired
177,563

 
 
Fair value of liabilities assumed:
 
 
 
Accounts payable
10,292

 
 
Accrued liabilities
15,579

 
 
Current portion of capital lease obligations
4,664

 
 
Current portion of long-term debt
3,027

 
 
Long-term capital lease obligations
3,420

 
 
Deferred tax liabilities
14,465

 
 
Other long-term liabilities
32,364

 
 
Total liabilities assumed
83,811

 
 
 
 
 
 
Total identifiable net assets
93,752

 
 
Fair value of noncontrolling interest
(9,961
)
 
 
Goodwill
198,783

 
 
Net assets acquired
$
282,574

 
 
We have integrated the operations of LifeWatch into our Healthcare segment. As a result of this integration, it is impracticable to disclose the amount of revenue and income/(loss) attributable to LifeWatch.

4. Inventory
Inventory consists of the following:
(in thousands)
September 30,
2018
 
December 31,
2017
Raw materials and supplies
$
5,367

 
$
3,128

Finished goods
3,419

 
2,204

Total inventory
$
8,786

 
$
5,332


21

 << Previous Page | Next Page >>